Rigel Share Price

Rigel Share Price

NASDAQ: RIGL | Small Cap | Healthcare
$41.30
-$1.27 (-2.98%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Rigel Stock Performance

Open
$41.38
Prev. Close
$42.57
Circuit Range
N/A
Day Range
$41.17 - $41.48
Year Range
$25.07 - $52.05
Volume
4,772
Average Traded
$41.31

Rigel Share Price Today

As of 20 November 2026, Rigel Pharmaceuticals, Inc.'s share price is $41.30. The stock opened at $41.38, compared to its previous close of $42.57. During today's trading session, Rigel Pharmaceuticals, Inc.'s share price traded between $41.17 and $41.48, with an average price of $41.33. Over the past 52 weeks, the stock has recorded a high of $52.05 and a low of $25.07. In terms of performance, Rigel Pharmaceuticals, Inc.'s share price has risen by 35.37% over the last six months and is down 18.29% on a year-on-year basis.

Rigel Share Price Chart

Line chart of the Rigel price trend over the selected period. The price fell overall, ranging from 42.26 to 43.59, ending at 42.56.
$41.17$41.48
L
Show Current Price
H

Rigel Stock Fundamentals & Key Indicators

Market Cap
$742.86M
PE Ratio (TTM)
2.61
Dividend Yield
0.00%
EPS (TTM)
$16.31
Revenue (TTM)
$294.28B
Return On Equity (TTM)
69.02%
Profit Margin
124.72%
Debt to Equity
0.02
Quarterly Earnings Growth YoY
-95.08%

Rigel Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$69.80$58.82$78.70$80.89
Net Profit$268.07$8.65$17.29$13.19
Net Profit Margin384.05%14.71%21.97%16.31%
Income ChangeN/A-96.77%99.88%-23.71%

Rigel Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$120.24$116.88$179.28$294.28
Net Profit-$58.57-$25.09$17.49$367.02
Net Profit Margin-48.71%-21.47%9.76%124.72%
Income ChangeN/A57.16%169.71%1998.46%

Rigel Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets273.4328.8717.9618.38
Current Assets240.17135.199.27115.9
Total Assets513.59163.98117.23134.28
Non Current Liabilities22.8897.3992.682.68
Current Liabilities99.2463.353.2765.21
Total Liabilities122.11160.69145.87147.9
Shareholders' Equity391.483.29-28.64-13.62

Rigel Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating75.6631.47-5.74-73.76
Investing-92.374.13-4.372.78
Financing0.6-11.6418.376.55

Corporate Actions

Split
Ex-date: 27 Jun 2024

About Rigel

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.

Rigel Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$51.25
$41.22
-19.80%
Oct 2026
$48.09
$51.39
+6.86%
Sep 2026
$46.81
$48.09
+2.64%
Aug 2026
$36.67
$46.85
+27.29%
Jul 2026
$38.97
$36.81
-5.90%
Jun 2026
$30.35
$39.12
+28.22%
May 2026
$29.44
$30.51
+5.52%
Apr 2026
$27.44
$28.91
+6.84%
Mar 2026
$33.88
$27.07
-21.85%
Feb 2026
$34.73
$34.63
-0.03%
Jan 2026
$42.67
$34.64
-19.06%
Dec 2025
$49.75
$42.80
-15.33%

Rigel Share Price FAQs